(Press-News.org) A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children’s Hospital of Chicago, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication. The findings offer unprecedented insight into preeclampsia prevention, independent of the direct effects of COVID-19 infection.
The study, published in eClinicalMedicine, titled COVID-19 Vaccination Status During Pregnancy and Preeclampsia Risk: The Pandemic-Era Cohort of the INTERCOVID Consortium, analysed data from 6,527 pregnant women across 18 countries enrolled between 2020 and 2022. Researchers compared vaccinated and unvaccinated women, with and without SARS-CoV-2 infection, to assess how vaccination status influenced preeclampsia rates.
“Our results support the importance of strengthening COVID vaccination programs during pregnancy, emphasising boosters and ensuring that pregnant people across the world have equitable access to the vaccine,” said study co-author Jagjit S. Teji, MD, a neonatologist at Lurie Children’s and Clinical Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine. “We offer evidence from the first large study suggesting that COVID vaccination may protect against one of the most serious pregnancy complications.”
Key Findings
COVID-19 infection during pregnancy was associated with a 45% increased risk of preeclampsia, which rose to 78% among unvaccinated women.
Vaccination reduced the overall odds of preeclampsia amongst women receiving a booster dose by 33%, statistically significant.
Among women with pre-existing health conditions such as diabetes, hypertension, or thyroid disorders, vaccination with a booster cut preeclampsia risk by 42%, statistically significant.
The protective effect of vaccination remained consistent after adjusting for key factors and may be extended beyond COVID-19 infection, suggesting potential benefits for preeclampsia prevention regardless of infection status.
Vaccinated women also experienced lower odds of preterm delivery, maternal and perinatal morbidity, and mortality.
In addition, amongst women that have a booster dose, the protective effect for preterm birth was 33%, maternal morbidity and mortality was 32%, severe perinatal morbidity and mortality was 29%, all of them statistically significant.
“These results go beyond the known benefits of COVID-19 vaccination in pregnancy,” said Professor José Villar, the senior co-author of the study and Principal Investigator of the INTERCOVID consortium from the Nuffield Department of Women’s & Reproductive Health, University of Oxford (UK). “We now have evidence that maternal vaccination may influence pathways involved in preeclampsia development, suggesting a broader immunological or vascular benefit of vaccination.”
Preeclampsia affects up to 3%-8% of pregnancies worldwide, depending on the risk profile, and is a leading cause of maternal and neonatal morbidity and mortality. The origins of preeclampsia are unknown and treatments and preventive measures must be improved, but inflammation, and vascular dysfunction are known contributors, mechanisms that overlap with COVID-19 infection.
The INTERCOVID findings support the idea that vaccination may modulate immune and vascular pathways involved in preeclampsia, potentially offering protection even in the absence of COVID-19 infection. This aligns with growing evidence that some vaccines may have beneficial “non-specific” effects on immune regulation.
The INTERCOVID consortium includes over 40 hospitals across 18 countries, reflecting a truly global effort to understand maternal and perinatal outcomes during the pandemic.
Ann & Robert H. Lurie Children’s Hospital of Chicago is a nonprofit organization committed to providing access to exceptional care for every child. It is the only independent, research-driven children’s hospital in Illinois and one of less than 35 nationally. This is where the top doctors go to train, practice pediatric medicine, teach, advocate, research and stay up to date on the latest treatments. Exclusively focused on children, all Lurie Children’s resources are devoted to serving their needs. Research at Lurie Children’s is conducted through Stanley Manne Children’s Research Institute, which is focused on improving child health, transforming pediatric medicine and ensuring healthier futures through the relentless pursuit of knowledge. Lurie Children’s is the pediatric training ground for Northwestern University Feinberg School of Medicine. It is ranked as one of the nation’s top children’s hospitals by U.S. News & World Report.
END
COVID-19 vaccination during pregnancy may help prevent preeclampsia
2026-02-19
ELSE PRESS RELEASES FROM THIS DATE:
Menopausal hormone therapy not linked to increased risk of death
2026-02-19
Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published by The BMJ today.
The findings support current guidelines that recommend hormone therapy for women who have recently begun menopause who have moderate to severe symptoms and no contraindications, say the researchers.
Menopausal hormone therapy can help relieve menopausal symptoms such as hot flashes, sleep disturbance, mood swings, and depression. But its use has steadily declined during the last two decades, mainly due to safety concerns, and real world evidence ...
Chronic shortage of family doctors in England, reveals BMJ analysis
2026-02-19
Four fifths of England’s integrated care boards (ICBs) - responsible for planning health services for their local population - would need to at least double their number of general practitioners to meet staffing standards considered safe for patients, finds an analysis of NHS workforce data published by The BMJ today.
The British Medical Association (BMA) says that, by 2040, England should have one full time equivalent (FTE) GP for every 1,000 patients, to ensure manageable workloads and patient safety.
But new data released last month shows ...
Booster jabs reduce the risks of COVID-19 deaths, study finds
2026-02-19
Booster vaccines reduced the risk of COVID‑19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the universities of Bristol and Oxford, provides further evidence of the effectiveness of booster vaccination against COVID-19.
The study, published in Vaccine today [18 February], also found that this effectiveness was similar for Moderna (BA.1 mRNA-1273) and Pfizer-BioNTech (BA.1 BNT162b2) booster vaccines, but protection declined over time.
Previous work has shown the initial COVID-19 vaccination was effective in reducing the risk ...
Screening increases survival rate for stage IV breast cancer by 60%
2026-02-19
Women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis.
This is in comparison to a survival rate of under 20% of those with stage IV breast cancer which was not detected through screening.
The study by King’s College London, Queen Mary University London, and the University of Southern Denmark, aimed to find out if the method by which breast cancer is detected impacts survival rates at different stages of the cancer.
These results, published in JNCI, suggest that even at the most ...
ACC announces inaugural fellow for the Thad and Gerry Waites Rural Cardiovascular Research Fellowship
2026-02-18
The American College of Cardiology will recognize Plicy Perez-Kersey, MD, as the first recipient of the Thad and Gerry Waites Rural Cardiovascular Research Fellowship Award. Perez-Kersey will be honored at American College of Cardiology’s Annual Scientific Session (ACC.26) taking place March 28 – 30, in New Orleans.
The Thad and Gerry Waites Rural Cardiovascular Research Fellowship was funded through Thad F. Waites, MD, MACC, in honor of his wife Gerry. It reflects their commitment to combating cardiovascular disparities and uplifting underserved populations through evidence-based clinical interventions and innovative research. ...
University of Oklahoma researchers develop durable hybrid materials for faster radiation detection
2026-02-18
NORMAN, Okla. – Researchers at the University of Oklahoma have developed new hybrid materials that challenge conventional thinking about how light-emitting compounds work and could advance the field of fast radiation detection. The research, published in the Journal of the American Chemical Society, presents a novel approach to designing layered perovskite materials that combine the best of both organic and inorganic components.
Perovskites are crystalline materials with a specific atomic arrangement that has made them increasingly important ...
Medicaid disenrollment spikes at age 19, study finds
2026-02-18
In most states, Medicaid eligibility rules shift at age 19, when individuals transition from child to adult classification. A new study led by the University of Chicago finds that this policy threshold coincides with a sharp spike in Medicaid disenrollment, exposing millions of young adults — including those with significant health needs — to potential gaps in insurance coverage.
In the study, published February 16 in JAMA Pediatrics, researchers observed that 13.4% of young adults with complex medical conditions were disenrolled at age 19, compared with 35.6% of those without complex conditions. Disenrollment was defined as two or more months without ...
Turning agricultural waste into advanced materials: Review highlights how torrefaction could power a sustainable carbon future
2026-02-18
Researchers have published a comprehensive review showing how a little-known thermal treatment called biomass torrefaction could transform agricultural and forestry waste into high-value carbon materials for energy storage, environmental cleanup, and medicine.
Biomass such as crop residues, wood waste, and municipal organics is one of the most abundant renewable carbon resources on Earth. Yet much of it is burned or discarded, releasing greenhouse gases and wasting potential value. The new review explains how torrefaction, a mild heating process performed at roughly 200 to 300 degrees Celsius in low-oxygen ...
New study warns emerging pollutants in livestock and aquaculture waste may threaten ecosystems and public health
2026-02-18
A new scientific review highlights a growing environmental challenge linked to modern food production. Researchers report that waste from livestock and aquaculture operations now contains a complex mix of emerging contaminants that can spread through ecosystems and ultimately affect human health.
The study synthesizes recent global research on so-called new contaminants, including antibiotic residues, antibiotic resistance genes, endocrine-disrupting chemicals, and microplastics. These pollutants originate from veterinary drugs, feed additives, plastic equipment, and intensive farming practices, and they can persist in soils, ...
Integrated rice–aquatic farming systems may hold the key to smarter nitrogen use and lower agricultural emissions
2026-02-18
A growing body of research suggests that integrating aquatic animals into rice farming could significantly improve nitrogen efficiency while reducing environmental pollution. A new review synthesizes recent scientific findings and proposes that activity at the soil–water interface is the critical engine driving these benefits.
Nitrogen fertilizer is essential for global food production, yet only about half of applied nitrogen is absorbed by crops. The remainder is lost through runoff, volatilization, or conversion to greenhouse gases, contributing to water pollution, climate change, and higher farming costs. Improving nitrogen efficiency is therefore a major goal for ...